IRIS
MARTELLUCCI, IGNAZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.856
EU - Europa 1.570
AS - Asia 973
SA - Sud America 123
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 43
OC - Oceania 3
Totale 4.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.818
RU - Federazione Russa 384
SG - Singapore 337
GB - Regno Unito 308
CN - Cina 281
IT - Italia 248
IE - Irlanda 182
VN - Vietnam 135
BR - Brasile 98
UA - Ucraina 88
SE - Svezia 86
FR - Francia 85
DE - Germania 80
HK - Hong Kong 74
FI - Finlandia 47
BD - Bangladesh 46
KR - Corea 29
IN - India 25
ZA - Sudafrica 24
CA - Canada 21
ES - Italia 14
MX - Messico 11
NL - Olanda 9
IQ - Iraq 8
TR - Turchia 8
BE - Belgio 7
PL - Polonia 7
VE - Venezuela 7
LT - Lituania 6
CI - Costa d'Avorio 5
IL - Israele 5
PE - Perù 5
AR - Argentina 4
CO - Colombia 4
JP - Giappone 4
NG - Nigeria 4
PK - Pakistan 4
AT - Austria 3
SC - Seychelles 3
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HR - Croazia 2
IR - Iran 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
FJ - Figi 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.569
Salva come PNG Salva come JPEG
Città #
Southend 262
Singapore 205
Dallas 191
Dublin 178
Fairfield 175
Ashburn 173
San Jose 116
Moscow 100
Santa Clara 92
Woodbridge 86
Chandler 84
Beijing 83
Seattle 76
Jacksonville 72
Hong Kong 70
Houston 69
Wilmington 63
Milan 54
Cambridge 48
Council Bluffs 48
Ann Arbor 44
Ho Chi Minh City 44
Siena 42
New York 41
Hanoi 37
Hefei 37
Los Angeles 34
Princeton 31
Munich 30
Nanjing 30
Seoul 29
Helsinki 25
Rome 24
Johannesburg 22
Lauterbourg 21
Shanghai 19
The Dalles 13
Boardman 12
London 12
San Diego 12
San Mateo 12
Florence 11
São Paulo 10
Figino 9
Málaga 9
Chicago 8
Columbus 8
Denver 8
Nanchang 8
Naples 8
Toronto 8
Turku 8
Brussels 7
Da Nang 7
Montreal 7
Warsaw 7
Amsterdam 6
Bologna 6
Boston 6
Buffalo 6
Cagliari 6
Dearborn 6
Düsseldorf 6
Abidjan 5
Baghdad 5
Catania 5
Haiphong 5
Nuremberg 5
Orem 5
Redondo Beach 5
San Francisco 5
Abuja 4
Ankara 4
Belo Horizonte 4
Bengaluru 4
Brooklyn 4
Changsha 4
Chennai 4
Dong Ket 4
Frankfurt am Main 4
Hebei 4
Ningbo 4
Palermo 4
Phoenix 4
Poplar 4
Renton 4
Washington 4
Aguascalientes 3
Atlanta 3
Can Tho 3
Curitiba 3
Fremont 3
Hangzhou 3
Kunming 3
Lima 3
Manchester 3
Mexico City 3
Mumbai 3
Newark 3
Paris 3
Totale 3.124
Salva come PNG Salva come JPEG
Nome #
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 346
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 323
A62Effectiveness and resulting surgical behavior after neoadjuvant chemotherapy in locally advanced breast cancer: our experience 322
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients 268
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 268
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients 268
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience 265
Bevacizumab and weekly Doxetacel in patients with metastatic castrate-resistant prostate cancer previously exposed to Docetaxel 247
Effects of intravenous Zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from NSCLC 223
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 221
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 219
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients 219
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study 216
Porcelain gallbladder and its relationship to cancer 186
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 180
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 172
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractionated cisplatimum, oral etoposide, and bevacizumab 171
Sjögren's syndrome and aromatase inhibitors treatment: is there a link? 141
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 125
Rare variants modulating phenotype in NF1 carriers 93
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 86
Early psychological intervention in cancer patients: effects on emotional distress 40
Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab 22
null 3
Totale 4.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 0 20 14 19 15 11 9 10 12 31 33 57
2022/2023319 21 23 47 40 27 63 5 29 33 10 14 7
2023/2024293 5 5 24 13 10 88 105 9 3 12 3 16
2024/2025600 33 27 63 38 73 33 8 19 74 27 77 128
2025/20261.863 107 189 147 232 386 97 212 66 54 116 107 150
2026/2027100 58 42 0 0 0 0 0 0 0 0 0 0
Totale 4.624